HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Persistent interactions between biguanide-based compound NB325 and CXCR4 result in prolonged inhibition of human immunodeficiency virus type 1 infection.

Abstract
We previously demonstrated that the biguanide-based compound NB325 inhibits human immunodeficiency virus type 1 (HIV-1) infection by interacting with the CXCR4 viral coreceptor. This interaction also appeared to be persistent, since HIV-1 infection was inhibited even when the virus was introduced subsequent to the removal of NB325 from the cell culture medium. The present studies were conducted to determine the extent and mechanism of this prolonged antiviral activity. Persistent inhibition of HIV-1 infection by NB325 was concentration dependent and was apparent up to 8 h after removal of the compound. Flow cytometric analyses of stimulated CD4(+) T lymphocytes exposed to NB325 demonstrated concentration-dependent reductions in CXCR4 extracellular loop 2 epitope recognition that were maintained up to 24 h after removal of the compound. CXCL12-induced chemotaxis was also persistently inhibited following pre-exposure to NB325. These results demonstrate that persistent inhibition of X4 HIV-1 infection by NB325 involves extended perturbation of the viral coreceptor CXCR4.
AuthorsNina Thakkar, Vanessa Pirrone, Shendra Passic, Shawn Keogan, Wei Zhu, Vladyslav Kholodovych, William Welsh, Robert Rando, Mohamed Labib, Brian Wigdahl, Fred C Krebs
JournalAntimicrobial agents and chemotherapy (Antimicrob Agents Chemother) Vol. 54 Issue 5 Pg. 1965-72 (May 2010) ISSN: 1098-6596 [Electronic] United States
PMID20231400 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
Chemical References
  • Antiviral Agents
  • Biguanides
  • CXCR4 protein, human
  • Epitopes
  • NB325
  • Receptors, CXCR4
Topics
  • Antiviral Agents (metabolism, pharmacology, toxicity)
  • Biguanides (metabolism, pharmacology, toxicity)
  • CD4-Positive T-Lymphocytes (cytology, metabolism, virology)
  • Cells, Cultured
  • Chemotaxis, Leukocyte (drug effects, physiology)
  • Epitopes (drug effects)
  • Flow Cytometry
  • HIV Infections (drug therapy, metabolism)
  • HIV-1 (drug effects)
  • Humans
  • Inhibitory Concentration 50
  • Receptors, CXCR4 (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: